Source: https://www.law.cornell.edu/cfr/text/21/862.2270
Timestamp: 2015-05-05 02:39:23
Document Index: 307173083

Matched Legal Cases: ['art 862', '§ 862', 'art 807', '§ 862', 'art 820', '§ 820', '§ 820']

21 CFR 862.2270 - Thin-layer chromatography system for clinical use. | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter H › Part 862 › Subpart C › Section 862.2270 21 CFR 862.2270 - Thin-layer chromatography system for clinical use.
§ 862.2270
Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9. Particular components of TLC systems, i.e., the thin-layer chromatography apparatus, TLC atomizer, TLC developing tanks, and TLC ultraviolet light, are exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180 of this chapter, with respect to general requirements concerning records, and § 820.198 of this chapter, with respect to complaint files.